Find Clinical Trials | Cedars-Sinai

146 results found

Melanoma, Other Skin, Other Urinary, Ovary, Unknown Sites

IMC-F106C in Advanced Cancers

The purpose of this study is to determine the safety and effectiveness of an investigational immunotherapeutic drug called IMC-F106C in multiple cancers (endometrial, ovarian, melanoma, ocular melanoma, triple-negative breast, lung, and bladder cancer) expressing a ...

Leukemia, not otherwise specified

Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL

This study focuses on individuals who have been diagnosed with mixed-phenotype acute leukemia (MPAL). MPAL is a cancer of the white blood cells that occurs in the bone marrow and is a rare form of ...

Prostate

Mechanisms of Glutamine Metabolism in Prostate Cancer Progression

This study focuses on patients with a specific stage of prostate cancer known as metastatic, castration-sensitive or metastatic, castration-resistant prostate cancer who are still receiving androgen targeting therapy (a type of prostate cancer therapy). The ...

Lung

Biomarker-Driven Therapies and Immunotherapies in Non-Small Cell Lung Cancer

This study focuses on patients with non-small cell lung cancer. The purpose is to study tumor tissue to determine whether a targeted or immunotherapy treatment will have an effect on specific genes and proteins in ...

Multiple Myeloma, Non-Hodgkin's Lymphoma

The Coronavirus Risk Associations and Longitudinal Evaluation Study

This study seeks to determine the sociodemographic, clinical, lifestyle/environmental, and molecular determinant of risks and outcomes including but not restricted to following groups of people: (1) patients with confirmed/suspected or possible SARS-CoV-2 exposure/COVID-19 infection, (2) ...